海利生物
(603718)
| 流通市值：48.11亿 | | | 总市值：49.15亿 |
| 流通股本：6.44亿 | | | 总股本：6.58亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 77,525,211.08 | 37,207,690.91 | 60,261,265.57 | 140,736,190.61 |
| 应收票据及应收账款 | 90,817,823.18 | 85,339,472.73 | 96,564,957.56 | 84,947,031.64 |
| 其中：应收票据 | 614,960 | 460,750 | - | - |
| 应收账款 | 90,202,863.18 | 84,878,722.73 | 96,564,957.56 | 84,947,031.64 |
| 预付款项 | 7,710,601.77 | 5,643,955.3 | 9,404,955.51 | 8,988,516.19 |
| 其他应收款合计 | 106,479,598.61 | 8,900,735.94 | 10,946,940.18 | 4,912,189.76 |
| 存货 | 84,788,878.06 | 102,807,986.79 | 93,045,354.79 | 102,823,736.71 |
| 其他流动资产 | 11,650,861.07 | - | - | - |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,169,792,575.23 | 523,376,933.68 | 556,092,338.5 | 562,551,299.58 |
| 非流动资产: | | | | |
| 长期股权投资 | - | 628,695,663.65 | 622,701,440.03 | 626,189,856.64 |
| 其他非流动金融资产 | 12,902,809.16 | 12,902,809.16 | 12,902,809.16 | 12,902,809.16 |
| 固定资产 | 147,905,610.66 | 152,797,934.48 | 157,972,685.05 | 162,625,878.61 |
| 在建工程 | 754,300.97 | 754,300.97 | 754,300.97 | 754,300.97 |
| 使用权资产 | 4,403,362.23 | 283,451.64 | 753,898.83 | 1,224,346.02 |
| 无形资产 | 28,637,406.59 | 31,792,293.56 | 34,947,180.53 | 38,102,067.49 |
| 商誉 | 225,330,348.7 | 225,330,348.7 | 225,330,348.7 | 225,330,348.7 |
| 长期待摊费用 | 8,099,813.55 | 8,467,521.82 | 8,788,555.8 | 9,164,347.38 |
| 递延所得税资产 | 21,709,942.01 | 14,361,127.09 | 21,364,787.24 | 18,603,478.79 |
| 其他非流动资产 | 4,179,500 | 4,387,350 | 3,557,215 | 301,050 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 453,923,093.87 | 1,079,772,801.07 | 1,089,073,221.31 | 1,095,198,483.76 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,623,715,669.1 | 1,603,149,734.75 | 1,645,165,559.81 | 1,657,749,783.34 |
| 流动负债: | | | | |
| 短期借款 | 60,913,429 | 61,500,000 | 70,000,000 | 50,000,000 |
| 应付票据及应付账款 | 21,876,109.83 | 23,039,137.64 | 22,739,984.91 | 30,139,147.89 |
| 应付账款 | 21,876,109.83 | 23,039,137.64 | 22,739,984.91 | 30,139,147.89 |
| 合同负债 | 3,428,244.66 | 18,793,656.31 | 13,323,458.16 | 21,611,881.45 |
| 应付职工薪酬 | 3,552,913.92 | 3,372,701.36 | 3,261,081.23 | 7,130,500.23 |
| 应交税费 | 1,490,744.6 | 1,728,936.65 | 6,196,086.06 | 6,234,512.03 |
| 其他应付款合计 | 279,679,100.09 | 262,369,881.99 | 282,667,886.09 | 300,505,988.19 |
| 一年内到期的非流动负债 | - | 48,085.06 | 317,592.16 | 828,771.28 |
| 其他流动负债 | 102,847.34 | 563,809.69 | 333,068.68 | 586,254.14 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 371,043,389.44 | 371,416,208.7 | 398,839,157.29 | 417,037,055.21 |
| 非流动负债: | | | | |
| 租赁负债 | 4,074,606.31 | - | - | - |
| 递延收益 | 20,737,485.28 | 21,160,985.26 | 64,029,093.49 | 64,452,593.47 |
| 递延所得税负债 | 2,190,089.48 | 1,418,480.71 | 1,592,238.39 | 1,467,922.7 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 27,002,181.07 | 22,579,465.97 | 65,621,331.88 | 65,920,516.17 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 398,045,570.51 | 393,995,674.67 | 464,460,489.17 | 482,957,571.38 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 657,900,000 | 657,900,000 | 657,900,000 | 657,900,000 |
| 资本公积 | 282,310,065.09 | 262,574,714.63 | 248,230,091.43 | 229,685,473.44 |
| 减:库存股 | 66,043,070 | 66,442,000 | 66,442,000 | 66,442,000 |
| 其他综合收益 | -1,002,592.53 | -11,474,733.62 | -10,841,887.21 | -2,571,231.12 |
| 盈余公积 | 91,289,475.37 | 90,784,631.47 | 88,900,199.06 | 89,272,135.74 |
| 未分配利润 | 308,408,915.3 | 322,747,050.2 | 305,787,158.55 | 309,134,588.68 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,272,862,793.23 | 1,256,089,662.68 | 1,223,533,561.83 | 1,216,978,966.74 |
| 少数股东权益 | -47,192,694.64 | -46,935,602.6 | -42,828,491.19 | -42,186,754.78 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,225,670,098.59 | 1,209,154,060.08 | 1,180,705,070.64 | 1,174,792,211.96 |
| 负债和股东权益合计 | 1,623,715,669.1 | 1,603,149,734.75 | 1,645,165,559.81 | 1,657,749,783.34 |
| 公告日期 | 2024-10-31 | 2024-08-31 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |